Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of this research was to evaluate a redesigned impactor stage for the TSI Model 3306 Impactor Inlet with nozzles adjusted to obtain a target cut-point of 4.7 μm. It has been determined that the previous cut-point used in the Model 3306 was nominally closer to 4.14 μm, thus potentially impacting the characterization of aerosol mass. The reassessment of the Model 3306 was performed on 4 solution and 2 suspension metered-dose inhaler (MDI) formulations. The redesigned impactor stage resulted in a 5% to 6% increase in aerosol mass when compared with the previous impactor stage for the products Ventolin-HFA, Proventil-HFA, and 2 cyclosporin solution formulations with high ethanol concentrations (15% wt/wt). For the formulations with low ethanol concentrations (3% wt/wt), minimal differences were observed between the 2 cut-points. In addition, this study reevaluated the requirement of a vertical inlet extension length when using the TSI 3306/3321 system with the redesigned cut-point. It was shown that the use of a 20-cm extension provides mass and aerosol size distributions that are comparable to the Andersen 8-stage Cascade Impactor, for both solution and suspension MDIs. This work indicates that the TSI 3306/3321 system is suitable for preformulation studies of both suspension and solution MDI systems.

          Related collections

          Author and article information

          Journal
          AAPS PharmSciTech
          AAPS PharmSciTech
          Springer Nature America, Inc
          1530-9932
          1530-9932
          Mar 2006
          : 7
          : 1
          Affiliations
          [1 ] College of Pharmacy, University of Arizona, 1703 East Mabel St, 85719, Tucson, AZ. harris@pharmacy.arizona.edu.
          [2 ] Early Pharmaceutics and Technology Laboratory, 3M Drug Delivery Systems, St Paul, MN.
          [3 ] College of Pharmacy, University of Arizona, 1703 East Mabel St, 85719, Tucson, AZ.
          Article
          10.1208/pt070120
          10.1208/pt070120
          28290035

          Comments

          Comment on this article